Robotics, software-defined vehicles and autonomy
SDV architecture, ADAS and autonomy strategy, energy storage, and the reliability questions that decide whether humanoids scale.
SDVGuruA car on Autopilot and a Phase 2 oncology protocol look unrelated.
Underneath, both ask the same thing. Is this model safe enough to act on, and what can't the validation data tell you?
I've worked on that question for about twenty years. At Tesla the model drove the car. At Roche it supported oncology care teams. At Atheris it reads clinical trial protocols before a sponsor commits sites to them. The industries changed more often than the question did.